Temporal- and dose-dependent hepatic gene expression changes in immature ovariectomized mice following exposure to ethynyl estradiol

Carcinogenesis

Volumn 25, Issue 7, 2004, Pages 1277-1291

  Boverhof, D R ^a   Fertuck, K C ^a   Burgoon, L D ^a,b   Eckel, J E ^c   Gennings, C ^c   Zacharewski, T R ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ETHINYLESTRADIOL;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; DOSE RESPONSE; EXPRESSED SEQUENCE TAG; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC DATABASE; GENETIC IDENTIFICATION; LIPID METABOLISM; LIPID TRANSPORT; LIVER TOXICITY; MICROTUBULE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; OXIDATIVE STRESS; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; UNINDEXED SEQUENCE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; LIVER; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIECTOMY; TIME FACTORS; UTERUS;

EID: 3242778662     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh114     Document Type: Review

References (87)

1. Williams,C.L. and Stancel,G.M. (1996) Estrogens and progestins. In Hardman,J.G., Limbird,L.E., Molinoff,P.B., Ruddon,R.W. and Gilman,A.G. (eds), The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, pp. 1411-1440.
2. Kanamori,H., Krieg,S., Mao,C., Di Pippo,V.A., Wang,S., Zajchowski,D.A. and Shapiro,D.J. (2000) Proteinase inhibitor 9, an inhibitor of granzyme B-mediated apoptosis, is a primary estrogen-inducible gene in human liver cells. J. Biol. Chem., 275, 5867-5873.
3. Zumbado,M., Boada,L.D., Torres,S., Monterde,J.G., Diaz-Chico,B.N., Afonso,J.L., Cabrera,J.J. and Blanco,A. (2002) Evaluation of acute hepatotoxic effects exerted by environmental estrogens nonylphenol and 4-octylphenol in immature male rats. Toxicology, 175, 49-62.
4. Diel,P. (2002) Tissue-specific estrogenic response and molecular mechanisms. Toxicol. Lett., 127, 217-224.
5. Matthews,J., Celius,T., Halgren,R. and Zacharewski,T. (2000) Differential estrogen receptor binding of estrogenic substances: a species comparison. J. Steroid Biochem. Mol. Biol., 74, 223-234.
6. Villa,E., Grottola,A., Colantoni,A., De Maria,N., Buttafoco,P., Ferretti,I. and Manenti,F. (2002) Hepatocellular carcinoma: role of estrogen receptors in the liver. Ann. N. Y. Acad. Sci., 963, 37-45.
7. Kuiper,G.G., Carlsson,B., Grandien,K., Enmark,E., Haggblad,J., Nilsson,S. and Gustafsson,J.A. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology, 138, 863-870.
8. Petersen,D.N., Tkalcevic,G.T., Koza-Taylor,P.H., Turi,T.G. and Brown,T.A. (1998) Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. Endocrinology, 139, 1082-1092.
9. Watson,C.S., Campbell,C.H. and Gametchu,B. (2002) The dynamic and elusive membrane estrogen receptor-alpha. Steroids, 67, 429-437.
10. Ciana,P., Raviscioni,M., Mussi,P., Vegeto,E., Que,I., Parker,M.G., Lowik,C. and Maggi,A. (2003) In vivo imaging of transcriptionally active estrogen receptors. Nat. Med., 9, 82-86.
11. Nagel,S.C., Hagelbarger,J.L. and McDonnell,D.P. (2001) Development of an ER action indicator mouse for the study of estrogens, selective ER modulators (SERM5) and Xenobiotics. Endocrinology, 142, 4721-4728.
12. Lee,C.H. and Edwards,A.M. (2001) Stimulation of DNA synthesis and c-fos mRNA expression in primary rat hepatocytes by estrogens. Carcinogenesis, 22, 1473-1481.
13. De Maria,N., Manno,M. and Villa,E. (2002) Sex hormones and liver cancer. Mol. Cell. Endocrinol., 193, 59-63.
14. Chiu,E.J., Lin,H.L., Chi,C.W., Liu,T.Y. and Lui,W.Y. (2002) Estrogen therapy for hepatectomy patients with poor liver function? Med. Hypotheses, 58, 516-518.
15. Srivastava,R.A., Srivastava,N., Averna,M., Lin,R.C., Korach,K.S., Lubahn,D.B. and Schonfeld,G. (1997) Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. J. Biol. Chem., 272, 33360-33366.
16. Crocenzi,F.A., Sanchez Pozzi,E.J., Pellegrino,J.M., Favre,C.O., Rodriguez Garay,E.A., Mottino,A.D., Coleman,R. and Roma,M.G. (2001) Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets. Hepatology, 34, 329-339.
17. Yager,J.D. (2000) Endogenous estrogens as carcinogens through metabolic activation. J. Natl Cancer Inst. Monogr., 67-73.
18. Bolt,H.M. (1979) Metabolism of estrogens - natural and synthetic. Pharmocol. Ther., 4, 155-181.
19. Hyder,S.M., Chiappetta,C. and Stancel,G.M. (1999) Synthetic estrogen l7alpha-ethinyl estradiol induces pattern of uterine gene expression similar to endogenous estrogen 17beta-estradiol. J. Pharmacol. Exp. Ther., 290, 740-747.
20. Rozen,S. and Skaletsky,H.J. (2000) Primer3 on the WWW for general users and for biologist programmers. In Krawetz,S.M.S. (ed.), Bioinformatics Methods and Protocols. Methods in Molecular Biology. Humana Press, Totowa, NJ, pp. 365-386.
21. Hewitt,S.C., Deroo,B.J., Hansen,K., Collins,J., Grissom,S., Afshari,C.A. and Korach,K.S. (2003) Estrogen receptor dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Mol. Endocrinol., 17, 2070-2083.
22. Frasor,J., Danes,J.M., Komm,B., Chang,K.C., Lyttle,C.R. and Katzenellenbogen,B.S. (2003) Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology, 144, 4562-4574.
23. Yuen,T., Wurmbach,E., Pfeffer,R.L., Ebersole,B.J. and Sealfon,S.C. (2002) Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res., 30, e48.
24. Odum,J., Lefevre,P.A., Tittensor,S., Paton,D., Routledge,E.J., Beresford,N.A., Sumpter,J.P. and Ashby,J. (1997) The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols and comparison with a yeast estrogenicity assay. Regul. Toxicol. Pharmacol., 25, 176-188.
25. Charles,G.D., Gennings,C., Zacharewski,T.R., Gollapudi,B.B. and Carney,E.W. (2002) An approach for assessing estrogen receptor-mediated interactions in mixtures of three chemicals: a pilot study. Toxicol. Sci., 68, 349-360.
26. Fertuck,K.C., Eckel,J.E., Gennings,C. and Zacharewski,T.R. (2003) Identification of temporal patterns of gene expression in the uteri of immature, ovariectomized mice following exposure to ethynylestradiol. Physiol. Genom., 15, 127-141.
27. Hammond,G.L. (2002) Access of reproductive steroids to target tissues. Ohstet. Gynecol. Clin. North Am., 29, 411-423.
28. Weisz,A. and Bresciani,F. (1993) Estrogen regulation of proto-oncogenes coding for nuclear proteins. Crit. Rev. Oncog., 4, 361-388.
29. Weisz,A. and Breseiani,F. (1988) Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol. Endocrinol., 2, 816-824.
30. Himeno,Y., Fukuda,Y., Hatanaka,M. and Imura,H. (1989) Expression of oncogenes during rat chemical hepatotumorigenesis promoted by estrogen. Jpn. J. Cancer Res., 80, 737-742.
31. Payraudeau,V., Sarsat,J.P., Sobczak,J., Brechot,C. and Albaladejo,V. (1998) Cyclin A2 and c-myc mRNA expression in ethinyl estradiol induced liver proliferation. Mol. Cell. Endocrinol., 143, 107-116.
32. Chiappetta,C., Kirkland,J.L., Loose-Mitchell,D.S., Murthy,L. and Stancel,G.M. (1992) Estrogen regulates expression of the jun family of protooncogenes in the uterus. J. Steroid Biochem. Mol. Biol., 41, 113-123.
33. Sampath,D., Winneker,R.C. and Zhang,Z. (2001) Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer. Endocrinology, 142, 2540-2548.
34. Tsai,M.S., Bogart,D.F., Li,P., Mehmi,I. and Lupu,R. (2002) Expression and regulation of Cyr61 in human breast cancer cell lines. Oncogene, 21, 964-973.
35. Shoji,W., Inoue,T., Yamamoto,T. and Obinata,M. (1995) MIDA1, a protein associated with Id, regulates cell growth. J. Biol. Chem., 270, 24818-24825.
36. Leu,J.I., Crissey,M.A., Craig,L.E. and Taub,R. (2003) Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation. Mol. Cell. Biol., 23, 1251-1259.
37. Daikoku,T., Matsumoto,H., Gupta,R.A., Das,S.K., Gassmann,M., DuBois,R.N. and Dey,S.K. (2003) Expression of hypoxia-inducible factors in the peri-implantation mouse uterus is regulated in a cell-specific and ovarian steroid hormone-dependent manner. Evidence for differential function of HIFs during early pregnancy. J. Biol. Chem., 278, 7683-7691.
38. Safe S. (2001) Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam. Horm., 62, 231-252.
39. Jelinsky,S.A., Harris,H.A., Brown,E.L., Flanagan,K., Zhang,X., Tunkey,C., Lai,K., Lane,M.V., Simcoe,D.K. and Evans,M.J. (2003) Global transcription profiling of estrogen activity: estrogen receptor alpha regulates gene expression in the kidney. Endocrinology, 144, 701-710.
40. Bjornstrom,L. and Sjoberg,M. (2002) Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol. Endocrinol., 16, 2202-2214.
41. Lai,K., Harnish,D.C. and Evans,M.J. (2003) Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner. J. Biol. Chem., 278, 36418-36429.
42. St-Pierre,B., Flock,G., Zacksenhaus,E. and Egan,S.E. (2002) Stra13 homodimers repress transcription through class B E-box elements. J. Biol. Chem., 277, 46544-46551.
43. Chen,B. and Lim,R.W. (1997) Physical and functional interactions between the transcriptional inhibitors Id3 and ITF-2b. Evidence toward a novel mechanism regulating muscle-specific gene expression. J. Biol. Chem., 272, 2459-2463.
44. Shi,Y.E. and Yager,J.D. (1989) Effects of the liver tumor promoter ethinyl estradiol on epidermal growth factor-induced DNA synthesis and epidermal growth factor receptor levels in cultured rat hepatocytes. Cancer Res., 49, 3574-3580.
45. Ni,N. and Yager,J.D. (1994) Comitogenic effects of estrogens on DNA synthesis induced by various growth factors in cultured female rat hepatocytes. Hepatology, 19, 183-192.
46. Mori,H., Niwa,K., Zheng,Q., Yamada,Y., Sakata,K. and Yoshimi,N. (2001) Cell proliferation in cancer prevention; effects of preventive agents on estrogen-related endometrial carcinogenesis model and on an in vitro model in human colorectal cells. Mutat. Res., 480/481, 201-207.
47. Bover,L., Barrio,M., Bravo,A.I., Slavutsky,I., Larripa,I., Bolondi,A., Ayala,M. and Mordoh,J. (1998) The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo. Cell. Mol. Biol., 44, 493-504.
48. Yager,J.D., Roebuck,B.D., Paluszcyk,T.L. and Memoli,V.A. (1986) Effects of ethinyl estradiol and tamoxifen on liven DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. Carcinogenesis, 7, 2007-2014.
49. Hsu,C.Y. and Frankel,F.R. (1987) Effect of estrogen on the expression of mRNAs of different actin isoforms in immature rat uterus. Cloning of alpha-smooth muscle actin message. J. Biol. Chem., 262, 9594-9600.
50. Chiavegato,A., Capriani,A., Azzarello,G., Vinante,O., Pauletto,P. and Sartore,S. (1996) Expression of non-muscle myosin isoforms in rabbit myometrium is estrogen-dependent. Cell Tissue Res., 283, 7-18.
51. Sanchez-Ortiz,R.F., Wang,Z., Menon,C., DiSanto,M.E., Wein,A.J. and Chacko,S. (2001) Estrogen modulates the expression of myosin heavy chain in detrusor smooth muscle. Am. J. Physiol. Cell Physiol., 280, C433-440.
52. Pastore,G.N., Dicola,L.P., Dollahon,N.R. and Gardner,R.M. (1992) Effect of estriol on the structure and organization of collagen in the lamina propria of the immature rat uterus. Biol. Reprod., 47, 83-91.
53. Mercier,I., Colombo,F., Mader,S. and Calderone,A. (2002) Ovarian hormones induce TGF-beta (3) and fibronectin mRNAs but exhibit a disparate action on cardiac fibroblast proliferation. Cardiovasc. Res., 53, 728-739.
54. Woodward,T.L., Mienaltowski,A.S., Modi,R.R., Bennett,J.M. and Haslam,S.Z. (2001) Fibronectin and the alpha (5)beta (1) integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology, 142, 3214-3222.
55. Cicatiello,L., Ambrosino,C., Coletta,B., Scalona,M., Sica,V., Bresciani,F. and Weisz,A. (1992) Transcriptional activation of jun and actin genes by estrogen during mitogenic stimulation of rat uterine cells. J. Steroid Biochem. Mol. Biol., 41, 523-528.
56. Ochi, T. (1999) Induction of multiple microtubule-organizing centers, multipolar spindles and multipolar division in cultured V79 cells exposed to diethylstilbestrol, estradiol-17beta and bisphenol A. Mutat. Res., 431, 105-121.
57. Hirsimaki,P., Aaltonen,A. and Mantyla,E. (2002) Toxicity of antiestrogens. Breast J., 8, 92-96.
58. Dobles,M., Liberal,V., Scott,M.L., Benezra,R. and Sorger,P.K. (2000) Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell, 101, 635-645.
59. Michel,L.S., Liberal,V., Chatterjee,A., Kirchwegger,R., Pasche,B., Gerald,W., Dobles,M., Sorger,P.K., Murty,V.V. and Benezra,R. (2001) MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature, 409, 355-359.
60. Teng,J., Takei,Y., Harada,A., Nakata,T., Chen,J. and Hirokawa,N. (2001) Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth and microtubule organization. J. Cell Biol., 155, 65-76.
61. Harrison,A. and King,S.M. (2000) The molecular anatomy of dynein. Essays Biochem., 35, 75-87.
62. Doxsey,S.J., Stein,P., Evans,L., Calarco,P.D. and Kirschner,M. (1994) Penicentrin, a highly conserved centrosome protein involved in microtubule organization. Cell, 76, 639-650.
63. Milisav,I. (1998) Dynein and dynein-related genes. Cell Motil. Cytoskeleton, 39, 261-272.
64. Jefcoate,C.R., Liehr,J.G., Santen,R.J. et al. (2000) Tissue-specific synthesis and oxidative metabolism of estrogens. J. Natl Cancer Inst. Monogr., 95-112.
65. Keeney,D.S., Skinner,C., Travers,J.B., Capdevila,J.H., Nanney,L.B., King,L.E.,Jr and Waterman,M.R. (1998) Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate monooxygenase activity. J. Biol. Chem., 273, 32071-32079.
66. Vianello,S., Waterman,M.R., Dalla Valle,L. and Colombo,L. (1997) Developmentally regulated expression and activity of 17alpha-hydroxylase/C-17,20-lyase cytochrome P450 in rat liver. Endocrinology, 138, 3166-3174.
67. Yamamoto,M., Sakuma,T., Ichimaru,H. and Nemoto,N. (2001) Localization of estradiol-responsive region in the phenobarbital-responsive enhancer module of mouse Cyp2b-10 gene. J. Biochem. Mol. Toxicol., 15, 76-82.
68. Djavaheri-Mergny,M., Accaoui,M.J., Rouillard,D. and Wietzerbin,J. (2002) Gamma-glutamyl transpeptidase activity mediates NF-kappaB activation through lipid peroxidation in human leukemia U937 cells. Mol. Cell. Biochem., 232, 103-111.
69. Raftogianis,R., Creveling,C., Weinshilboum,R. and Weisz,J. (2000) Estrogen metabolism by conjugation. J. Natl Cancer Inst. Monogr., 27, 113-124.
70. Knudsen,L.E., Loft,S.H. and Autrup,H. (2001) Risk assessment: the importance of genetic polymorphisms in man. Mutat. Res., 482, 83-88.
71. Hudson,C.E., DeHaven,J.E., Schulte,B.A. and Norris,J.S. (1999) Exogenous 17beta-estradiol blocks alpha and mu but not pi class glutathione S-transferase immunoreactivity in epithelium of Syrian hamster vas deferens. J. Histochem. Cytochem., 47, 91-98.
72. Watanabe,H., Suzuki,A., Mizutani,T., Khono,S., Lubahn,D.B., Handa,H. and Iguchi,T. (2002) Genome-wide analysis of changes in early gene expression induced by oestrogen. Genes Cells, 7, 497-507.
73. Jones,M.E., Thorburn,A.W., Britt,K.L. et al. (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl Acad. Sci. USA, 97, 12735-12740.
74. Archer,T.K., Tam,S.P., Deugau,K.V. and Deeley,R.G. (1985) Apolipoprotein C-II mRNA levels in primate liver. Induction by estrogen in the human hepatocarcinoma cell line, HepG2. J. Biol. Chem., 260, 1676-1681.
75. Tam,S.P., Archer,T.K. and Deeley,R.G. (1985) Effects of estrogen on apolipoprotein secretion by the human hepatocarcinoma cell line, HepG2. J. Biol. Chem., 260, 1670-1675.
76. Hussain,M.M., Kancha,R.K., Zhou,Z., Luchoomun,J., Zu,H. and Bakillah,A. (1996) Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim. Biophys. Acta, 1300, 151-170.
77. Duverger,N., Tremp,G., Caillaud,J.M., Emmanuel,F., Castro,G., Fruchart,J.C., Steinmetz,A. and Denefle,P. (1996) Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science, 273, 966-968.
78. Goldberg,I.J., Scheraldi,C.A., Yacoub,L.K., Saxena,U. and Bisgaier,C.L. (1990) Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J. Biol. Chem., 265, 4266-4272.
79. Jones,D.R., Schmidt,R.J., Pickard,R.T., Foxworthy,P.S. and Eacho,P.I. (2002) Estrogen receptor-mediated repression of human hepatic lipase gene transcription. J. Lipid Res., 43, 383-391.
80. Dichek,H.L., Brecht,W., Fan,J. et al. (1998) Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake. J. Biol. Chem., 273, 1896-1903.
81. Nogradi,A. (1998) The role of carbonic anhydrases in tumors. Am. J. Pathol., 153, 1-4.
82. Gartel,A.L. and Tyner,A.L. (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther., 1, 639-649.
83. Nardacci,R., Lo Iacono,O., Ciccosanti,F. et al. (2003) Transglutaminase type II plays a protective role in hepatic injury. Am. J. Pathol., 162, 1293-1303.
84. Wang,H.S. and Chard,T. (1999) IGFs and IGF-binding proteins in the regulation of human ovarian and endometrial function. J. Endocrinol., 161, 1-13.
85. Yager,J.D., Zurlo,J., Sewall,C.H., Lucier,G.W. and He,H. (1994) Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol. Carcinogenesis, 15, 2117-2123.
86. Naciff,J.M., Overmann,G.J., Torontali,S.M., Carr,G.J., Tiesman,J.P., Richardson,B.D. and Daston,G.P. (2003) Gene expression profile induced by 17 alpha-ethynyl estradiol in the prepubertal female reproductive system of the rat. Toxicol. Sci., 72, 314-330.
87. Orphanides,G. and Reinberg,D. (2002) A unified theory of gene expression. Cell, 108, 439-451